GlobeImmune Inc (GBIM)
0.00
USD |
OTCM |
Mar 27, 16:00
GlobeImmune Shareholders Equity (Quarterly): 2.150M for March 31, 2016
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2016 | 2.150M |
December 31, 2015 | 2.988M |
September 30, 2015 | 3.754M |
June 30, 2015 | 2.835M |
March 31, 2015 | 4.096M |
December 31, 2014 | 5.604M |
Date | Value |
---|---|
September 30, 2014 | 7.323M |
June 30, 2014 | -214.30M |
March 31, 2014 | -205.19M |
December 31, 2013 | -199.32M |
June 30, 2012 | -191.57M |
March 31, 2012 | -187.61M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
NovaBay Pharmaceuticals Inc | 7.037M |
Palatin Technologies Inc | -11.38M |
iBio Inc | 9.197M |
Theriva Biologics Inc | 43.88M |
Ampio Pharmaceuticals Inc | 5.375M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 9.771M |
Total Liabilities (Quarterly) | 7.621M |